No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ZBH240719C110000
- 0.25
- -1.85-88.10%
15min DelayClose Jul 19 16:00 ET
1.06High0.15Low
1.06Open2.10Pre Close114 Volume257 Open Interest110.00Strike Price10.23KTurnover104.00%IV-0.23%PremiumJul 19, 2024Expiry Date0.50Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.6709Delta0.3153Gamma147.33Leverage Ratio-5.8343Theta0.0001Rho98.85Eff Leverage0.0040Vega
Intraday
- 5D
- Daily
News
ZimVie Jumps After Report on Buyout Talks With South Korea's Osstem
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 23.7x Zimmer Biomet Holdings, Inc. (NYSE:ZBH) may be sending bearish signals at the moment, given that almost half of all companies in the United States
Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Announces Target Price $117
Truist Financial analyst Richard Newitter maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and sets the target price at $117.According to TipRanks data, the analyst has a success rate
Zimmer Biomet Holdings Is Maintained at Hold by Truist Securities
Zimmer Biomet Holdings Is Maintained at Hold by Truist
Morgan Stanley Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $120
Morgan Stanley analyst Drew Ranieri maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and maintains the target price at $120.According to TipRanks data, the analyst has a success rate
Express News | Zimmer Biomet Holdings Inc : Truist Securities Cuts Target Price to $117 From $130
Comments
Zimmer Biomet Holdings' statutory profit likely understates its earnings potential despite unusual items' impact. The company's impressive EPS growth over the last year indicates a promising future.
1
Zimmer Biomet Holdings may be undervalued, with stock growth not yet fully factored into its current price. A comprehensive understanding of its financial health and management track record is advised.
1
Zimmer Biomet's current trends do not fit the mold of a multi-bagger, as it isn't compounding its earnings but is generating stable returns. Given these factors, investors may have better chances looking elsewhere for a multi-bagger.
1
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Hasbro(HAS.US$ - up 1.9%
2. $Mitsubishi UFJ Financial Group(MUFG.US$ - up 1.7%
3. $Sumitomo Mitsui Financial(SMFG.US$ - up 1.4%
4. $Toyota Motor(TM.US$ - up 1.0%
5. $Vale SA(VALE.US$ - up 1.0%
6. $SAP SE(SAP.US$ - up 0.8%
7. $ArcelorMittal SA(MT.US$ - up 0.6%
Gap Downs
1. $Dick's Sporting Goods(DKS.US$ - down 19...
Gap Ups
1. $Hasbro(HAS.US$ - up 1.9%
2. $Mitsubishi UFJ Financial Group(MUFG.US$ - up 1.7%
3. $Sumitomo Mitsui Financial(SMFG.US$ - up 1.4%
4. $Toyota Motor(TM.US$ - up 1.0%
5. $Vale SA(VALE.US$ - up 1.0%
6. $SAP SE(SAP.US$ - up 0.8%
7. $ArcelorMittal SA(MT.US$ - up 0.6%
Gap Downs
1. $Dick's Sporting Goods(DKS.US$ - down 19...
+8
16
4
Read more